PNC Financial Services Group Inc. Has $2.24 Million Stock Holdings in Haleon plc (NYSE:HLN)

PNC Financial Services Group Inc. boosted its holdings in shares of Haleon plc (NYSE:HLN) by 3.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 211,326 shares of the company’s stock after buying an additional 6,381 shares during the period. PNC Financial Services Group Inc.’s holdings in Haleon were worth $2,236,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the business. Fortitude Family Office LLC purchased a new stake in shares of Haleon in the third quarter worth approximately $28,000. Cultivar Capital Inc. acquired a new stake in shares of Haleon during the 2nd quarter valued at $40,000. Hexagon Capital Partners LLC grew its holdings in shares of Haleon by 66.6% during the 2nd quarter. Hexagon Capital Partners LLC now owns 6,695 shares of the company’s stock valued at $55,000 after acquiring an additional 2,677 shares in the last quarter. BOKF NA increased its stake in shares of Haleon by 68.8% in the second quarter. BOKF NA now owns 6,972 shares of the company’s stock worth $58,000 after acquiring an additional 2,842 shares during the last quarter. Finally, Rothschild Investment LLC purchased a new stake in shares of Haleon during the second quarter worth $60,000. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

HLN has been the subject of a number of recent research reports. Berenberg Bank initiated coverage on Haleon in a research note on Tuesday, August 6th. They set a “buy” rating for the company. The Goldman Sachs Group downgraded shares of Haleon from a “buy” rating to a “neutral” rating in a research report on Tuesday, August 6th. UBS Group upgraded shares of Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Finally, Morgan Stanley upped their price objective on shares of Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a report on Friday, September 20th. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $10.95.

Haleon Price Performance

Shares of Haleon stock opened at $9.58 on Tuesday. Haleon plc has a 1-year low of $7.89 and a 1-year high of $10.80. The firm has a fifty day simple moving average of $10.01 and a 200-day simple moving average of $9.39. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $43.37 billion, a price-to-earnings ratio of 28.18, a PEG ratio of 2.91 and a beta of 0.30.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.